Methylene Blue in the Hepatopulmonary Syndrome
Authors:
- Giovanni RollaGRGiovanni Rolla
- Caterina BuccaCBCaterina Bucca
- Luisa BrussinoLBLuisa Brussino
- 20 October 1994
- journal article
- letter
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 331 (16) , 1098
Abstract
The hepatopulmonary syndrome, which is characterized by hypoxemia due to intrapulmonary shunting or a ventilation-perfusion mismatch (or both), develops in some patients with liver cirrhosis. Patients with this syndrome have no apparent parenchymal lung disease but may have orthodeoxia, the unusual finding of increased hypoxemia with the change from a supine to a standing position.1Keywords
This publication has 4 references indexed in Scilit:
- Nitric oxide in liver failureThe Lancet, 1991
- Mechanism of action of some inhibitors of endothelium-derived relaxing factor.Proceedings of the National Academy of Sciences, 1986
- Alveolar-Capillary Oxygen Disequilibrium in Hepatic CirrhosisChest, 1978
- Platypnea Related to Orthodeoxia Caused by True Vascular Lung ShuntsNew England Journal of Medicine, 1976